Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Jakob R, Passweg"'
Autor:
Caroline Arber, Gabriela Baerlocher, Yves Chalandon, Michael Daskalakis, Michel Duchosal, Martin Fehr, Sabine Gerull, Tayfun Güngör, Gayathri Nair, Thomas Pabst, Jakob R. Passweg, Barbara Piccolruaz, Christoph Renner, Axel Ruefer, Dominik Schneidawind, Georg Stüssi, Sacha Zeerleder, Jörg P. Halter
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 10 (2024)
No abstract available.
Externí odkaz:
https://doaj.org/article/1a08507158c34aa0be6c05c66d9e61ff
Autor:
Yoshiko Atsuta, Helen Baldomero, Daniel Neumann, Anna Sureda, Jakob D. DeVos, Minako Iida, Amado Karduss, Duncan Purtill, Alaa M. Elhaddad, Nosa G. Bazuaye, Carmem Bonfim, Rafael de la Camara, Naeem A. Chaudhri, Fabio Ciceri, Cinthya Correa, Cristobal Frutos, Sebastian Galeano, Laurent Garderet, Oscar Gonzalez-Ramella, Raffaella Greco, Nada Hamad, Mette D. Hazenberg, Mary M. Horowitz, Krzysztof Kalwak, Bor-Sheng Ko, Yoshihisa Kodera, Mickey BC Koh, Kaiyan Liu, Donal P. McLornan, Joon Ho Moon, Benedicte Neven, Shinichiro Okamoto, Marcelo C Pasquini, Jakob R. Passweg, Kristjan Paulson, Damiano Rondelli, Annalisa Ruggeri, Adriana Seber, John A. Snowden, Alok Srivastava, Jeff Szer, Daniel Weisdorf, Nina Worel, Hildegard Greinix, Wael Saber, Mahmoud Aljurf, Dietger Niederwieser
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Promoting access to and excellence in hematopoietic cell transplantation (HCT) by collecting and disseminating data on global HCT activities is one of the principal activities of the Worldwide Network for Blood and Marrow Transplantation, a non-Gover
Externí odkaz:
https://doaj.org/article/dcbc8f7bb65c4274993de5cc2382ba19
Autor:
Dominik Heim, Helen Baldomero, Michael Medinger, Stavroula Masouridi-Levrat, Urs Schanz, Gayathri Nair, Tayfun Güngör, Jörg Halter, Jakob R. Passweg, Yves Chalandon, Swiss Stem Cell Transplantation Group (SBST)
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 5 (2024)
AIM: Until the year 2000, allogeneic haematopoietic cell transplantation (HCT) was the standard treatment for young and fit chronic myeloid leukaemia (CML) patients. CML was the main indication for allogeneic HCT. The introduction of tyrosine kinase
Externí odkaz:
https://doaj.org/article/e094cf77c51f4bccbbba9ae93266b65f
Autor:
Sarah Jungius, Franziska C. Adam, Kerstin Grosheintz, Michael Medinger, Andreas Buser, Jakob R. Passweg, Jörg P. Halter, Sara C. Meyer
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionMyelofibrosis (MF) is a rare hematopoietic stem cell disorder progressing to bone marrow (BM) failure or blast phase. Allogeneic hematopoietic cell transplantation (HCT) represents a potentially curative therapy for a limited subset of pa
Externí odkaz:
https://doaj.org/article/ab130bbf154f40a89377d4418000d849
Autor:
Damien Luque Paz, Michael S. Bader, Ronny Nienhold, Shivam Rai, Tiago Almeida Fonseca, Jan Stetka, Hui Hao-Shen, Gabriele Mild-Schneider, Jakob R. Passweg, Radek C. Skoda
Publikováno v:
HemaSphere, Vol 7, Iss 5, p e885 (2023)
Myeloproliferative neoplasms (MPNs) are caused by a somatic gain-of-function mutation in 1 of the 3 disease driver genes JAK2, MPL, or CALR. About half of the MPNs patients also carry additional somatic mutations that modify the clinical course. The
Externí odkaz:
https://doaj.org/article/81859577bfc14bcca1747a3f6ad405a3
Autor:
Peter Dreger, Nathalie Fegueux, Urban Novak, Jakob R Passweg, Christian Chabannon, Arnold Ganser, Edouard Forcade, Rafael de la Cámara, Grzegorz W Basak, Christian Koenecke, Urs Schanz, Olaf Penack, Christophe Peczynski, Emmanuelle Polge, Andrea Kuhnl, Michael Daskalakis, Nicolaus Kröger, Caroline Besley, Adrian Bloor, Lucia López Corral, Ivan Moiseev, Hélène Schoemans, Anna Sureda, Dina Averbuch, Bertram Glass, Zinaida Peric
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 4 (2023)
We investigated the incidence and outcome of anti-CD19 chimeric antigen receptor (CAR) T-cells-associated Common Terminology Criteria for Adverse Events (CTCAE) ≥grade 3 cytopenia. In the EBMT CAR-T registry, we identified 398 adult patients with l
Externí odkaz:
https://doaj.org/article/671c0329917e4b598b9bb0701331071d
Autor:
Franziska C. Adam, Jakub Szybinski, Jörg P. Halter, Nathan Cantoni, Friedel Wenzel, Katharina Leonards, Sime Brkic, Jakob R. Passweg, Ivo Touw, Julia E. Maxson, Sara C. Meyer
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 805-815 (2022)
Chronic neutrophilic leukemia (CNL) relates to mutational CSF3R activation with membrane proximal CSF3R mutations such as T618I as driver mutations, but the significance of truncating mutations is not clarified. In CNL, concomitant mutations promote
Externí odkaz:
https://doaj.org/article/7c6926b7e08c4f438dc34b200fa1a338
Autor:
Jakob R Passweg, Dominik Heim, Katharina Baur, Astrid Beerlage, Anna S Poerings, Bastian Kopp, Michael Medinger, Jan C Dirks, Andreas Holbro
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 12 (2022)
Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are severe, potentially life-threatening side effects of chimeric antigen receptor T-cell (CAR T) therapy caused by the release of cytokines by prolife
Externí odkaz:
https://doaj.org/article/06820fb0139b4c2d934df387af8e13dd
Autor:
Nicolas Fattinger, Jan A. Roth, Helen Baldomero, Daiana Stolz, Michael Medinger, Dominik Heim, Michael Tamm, Jörg P. Halter, Jakob R. Passweg, Martina Kleber
Publikováno v:
HemaSphere, Vol 6, Iss 4, p e704 (2022)
Pretransplant risk scores such as the revised Pretransplant Assessment of Mortality (rPAM) score help to predict outcome of patients receiving allogeneic hematopoietic cell transplantation (allo-HCT). Since the rPAM has not been validated externally
Externí odkaz:
https://doaj.org/article/55051c2c8a8b4b52b16ab848842c78c3
Autor:
Peter Dreger, Paolo Pedrazzoli, Salvatore Siena, Christoph E Heilig, Stefan Fröhling, Massimo Di Nicola, Manuela Badoglio, Myriam Labopin, Simona Secondino, Jürgen Heinz, Emmanuelle Nicolas-Virelizier, Didier Blaise, Clément Korenbaum, Armando Santoro, Mareike Verbeek, William Krüger, Jakob R Passweg, Jose Rifón, Ulrike Koehl, Christian Chabannon
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background The role of high-dose chemotherapy with autologous stem cell transplantation (ASCT) in the treatment of soft-tissue sarcoma (STS) remains an unsettled issue. Prospective clinical trials failed to prove a benefit of the procedure but were l
Externí odkaz:
https://doaj.org/article/024631707b254e0887fad07c47174a09